Canaccord Genuity Maintains a 'Buy' on Halliburton (HAL); Macondo Report Confirms Limited Blame
Tweet
Share
E-mailGet Alerts HAL Hot Sheet
Price: $35.34 -0.98%
Rating Summary:
34 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
34 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Halliburton (NYSE: HAL) price target of $67.00.
Canaccord analyst, Scott Burk, says, "Early summaries overstated HAL blame. Early morning stories about the BOEMRE (Bureau of Ocean Energy Management, Regulation and Enforcement) report indicated shared responsibility for the blow out between BP (NYSE: BP), Transocean (NYSE: RIG) and HAL, but the report details largely exonerate HAL from blame, in our view...We would take advantage of any future Macondo-related downside to buy the stock."
For more ratings news on Halliburton click here and for the rating history of Halliburton click here.
Shares of Halliburton closed at $39.49 yesterday.
Canaccord analyst, Scott Burk, says, "Early summaries overstated HAL blame. Early morning stories about the BOEMRE (Bureau of Ocean Energy Management, Regulation and Enforcement) report indicated shared responsibility for the blow out between BP (NYSE: BP), Transocean (NYSE: RIG) and HAL, but the report details largely exonerate HAL from blame, in our view...We would take advantage of any future Macondo-related downside to buy the stock."
For more ratings news on Halliburton click here and for the rating history of Halliburton click here.
Shares of Halliburton closed at $39.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Curaleaf launches hostile takeover bid for Aurora Cannabis at $4/share
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
